PPARγ-inactive Δ2-troglitazone independently triggers ER stress and apoptosis in breast cancer cells

Christelle Colin-Cassin1, Xiao Yao, Claudia Cerella

  • 1Université de Lorraine, CRAN, UMR 7039, Vandœuvre-lès-Nancy, France; CNRS, CRAN, UMR 7039, Vandœuvre-lès-Nancy, France.

Molecular Carcinogenesis
|December 3, 2013
PubMed

Insights

Thiazolidinediones (TZDs) induce apoptosis in breast cancer cells via endoplasmic reticulum (ER) stress. This ER stress response occurs early, preceding apoptosis, but does not directly cause it, revealing novel anti-cancer pathways.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Biology

Background:

  • Thiazolidinediones (TZDs) are known for their anti-cancer properties, but the underlying mechanisms beyond PPARγ activation are not fully understood.
  • Investigating PPARγ-independent pathways is crucial for developing novel anti-cancer therapeutics.

Purpose of the Study:

  • To elucidate the PPARγ-independent anti-cancer effects of thiazolidinediones (TZDs) by focusing on Δ2-troglitazone (Δ2-TGZ).
  • To investigate the role of endoplasmic reticulum (ER) stress in mediating the anti-cancer effects of Δ2-TGZ in breast cancer cells.

Main Methods:

  • Treatment of MCF7 and MDA-MB-231 breast cancer cells with Δ2-TGZ.
  • Assessment of apoptosis using TUNEL assay, mitochondrial membrane potential, and PARP-1/caspase-7 cleavage.
  • Microarray analysis to identify cellular pathways affected by Δ2-TGZ.
  • Confirmation of ER stress markers including PERK, eIF2α, ATF3, XBP1, BiP, and CHOP.
  • Immunofluorescence microscopy for CHOP localization.
  • Gene knockdown (CHOP) and inhibitor studies (JNK).

Main Results:

  • Δ2-TGZ induced apoptosis in both hormone-dependent (MCF7) and hormone-independent (MDA-MB-231) breast cancer cells.
  • Microarray and subsequent validation confirmed ER stress as an early response to Δ2-TGZ, evidenced by upregulation of ER stress genes and key protein markers.
  • ER stress markers (PERK, eIF2α, ATF3, XBP1, BiP, CHOP) were rapidly activated in both cell lines.
  • CHOP relocalization to the nucleus was observed.
  • CHOP knockdown or JNK inhibition did not prevent apoptosis, indicating ER stress precedes but is not causative of apoptosis.

Conclusions:

  • Endoplasmic reticulum (ER) stress is an early, conserved response in major breast cancer subtypes treated with Δ2-TGZ.
  • This ER stress response occurs prior to the induction of apoptosis but is not the direct cause of apoptotic cell death.
  • These findings highlight a novel PPARγ-independent mechanism of TZD anti-cancer activity involving ER stress.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.0K
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.2K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
5.2K
Cell Specific Gene Expression01:58

Cell Specific Gene Expression

Multicellular organisms contain a variety of structurally and functionally distinct cell types, but the DNA in all the cells originated from the same parent cells. The differences in the cells can be attributed to the differential gene expression. Liver cells, whose functions include detoxification of blood, production of bile to metabolize fats, and synthesis of proteins essential for metabolism, must express a specific set of genes to perform their functions. Gene expression also varies with...
13.4K
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.2K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.6K